Bevacizumab with Chemotherapy for Lung Cancer
Author Information
Author(s): Lima André Bacellar Costa, Macedo Ligia T., Sasse André Deeke
Primary Institution: Universidade Estadual de Campinas (UNICAMP)
Hypothesis
Does the addition of bevacizumab to chemotherapy improve outcomes in patients with advanced non-small cell lung cancer?
Conclusion
Adding bevacizumab to chemotherapy in patients with advanced non-small cell lung cancer prolongs overall survival, progression-free survival, and response rates, but comes with increased risks of toxicity.
Supporting Evidence
- The addition of bevacizumab resulted in a significant longer overall survival compared to chemotherapy alone.
- Patients receiving bevacizumab had a longer progression-free survival.
- The overall response rate was higher in patients treated with bevacizumab plus chemotherapy.
Takeaway
This study found that giving a medicine called bevacizumab along with chemotherapy helps people with a type of lung cancer live a little longer, but it can also cause more side effects.
Methodology
This systematic review included randomized clinical trials comparing chemotherapy with or without bevacizumab in patients with advanced non-small cell lung cancer, analyzing overall survival, progression-free survival, response rates, and toxicities.
Potential Biases
There may be risks of bias due to the exclusion of certain trials and the reliance on published data.
Limitations
The study is limited by the quality and quantity of available data and potential publication bias.
Participant Demographics
The study included patients with advanced non-small cell lung cancer, primarily non-squamous histology.
Statistical Information
P-Value
p=0.04 for overall survival, p<0.00001 for progression-free survival, p<0.00001 for response rates
Confidence Interval
95% CI 0.79 to 0.99 for overall survival, 95% CI 0.66 to 0.82 for progression-free survival, 95% CI 1.89 to 2.89 for response rates
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website